UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Cancer immunotherapy μ-environment LabChip: taking advantage of optoelectronic tweezers

Lab on a chip, 2018-01, Vol.18 (1), p.106-114

2018

Volltextzugriff (PDF)

Cancer immunotherapy μ-environment LabChip: taking advantage of optoelectronic tweezersElectronic supplementary information (ESI) available: Video S1 shows the demonstration of TiOPc-based OET for precise manipulation of single micro-beads in a cancer immunotherapy μ-environment LabChip. Video S2 shows the diffusion in time series for PEG-DA hydrogel FLCS microwells. See DOI: 10.1039/c7lc00963a

2017-12

Volltextzugriff (PDF)

Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448

BMC cancer, 2016-02, Vol.16 (1), p.160-160, Article 160

2016

Volltextzugriff (PDF)

Piwi reduction in the aged niche eliminates germline stem cells via Toll-GSK3 signaling

Nature communications, 2020-06, Vol.11 (1), p.3147-13, Article 3147

2020

Volltextzugriff (PDF)

Synergistic disruption of BTK and BCL-2 causes apoptosis while inducing ferroptosis in double-hit lymphoma

European journal of pharmacology, 2023-03, Vol.943, p.175526-175526, Article 175526

2023

Volltextzugriff (PDF)

Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study

British journal of clinical pharmacology, 2021-12, Vol.87 (12), p.4670-4680

2021

Volltextzugriff (PDF)

Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors

CPT: pharmacometrics and systems pharmacology, 2022-07, Vol.11 (7), p.867-879

2022

Volltextzugriff (PDF)

HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1

Experimental cell research, 2018-09, Vol.370 (2), p.519-530

2018

Volltextzugriff (PDF)

Dihydroceramide desaturase regulates the compartmentalization of Rac1 for neuronal oxidative stress

Cell reports (Cambridge), 2021-04, Vol.35 (2), p.108972-108972, Article 108972

2021

Volltextzugriff (PDF)

Targeting FAT1 Inhibits Carcinogenesis, Induces Oxidative Stress and Enhances Cisplatin Sensitivity through Deregulation of LRP5/WNT2/GSS Signaling Axis in Oral Squamous Cell Carcinoma

Cancers, 2019-11, Vol.11 (12), p.1883

2019

Volltextzugriff (PDF)

Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma

Cancer letters, 2015-11, Vol.368 (1), p.36-45

2015

Volltextzugriff (PDF)

Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis

Arteriosclerosis, thrombosis, and vascular biology, 2017-01, Vol.37 (1), p.144

2017

Volltextzugriff (PDF)

Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients

Breast cancer research and treatment, 2022-04, Vol.192 (3), p.629-637

2022

Volltextzugriff (PDF)

A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

BMC cancer, 2016-11, Vol.16 (1), p.907, Article 907

2016

Volltextzugriff (PDF)

Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit

Molecular nutrition & food research, 2013-07, Vol.57 (7), p.1123-1134

2013

Volltextzugriff (PDF)

Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer

Journal of clinical medicine, 2019-01, Vol.8 (2), p.148

2019

Volltextzugriff (PDF)

4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells

Toxicology and applied pharmacology, 2021-07, Vol.422, p.115493, Article 115493

2021

Volltextzugriff (PDF)

The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity

Clinical & experimental metastasis, 2018-10, Vol.35 (7), p.663-677

2018

Volltextzugriff (PDF)

Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression

Disease markers, 2022-07, Vol.2022, p.1-16

2022

Volltextzugriff (PDF)

Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity

Cancer letters, 2015-08, Vol.364 (2), p.125-134

2015

Volltextzugriff (PDF)

Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy

Theranostics, 2021-01, Vol.11 (8), p.3624-3641

2021

Volltextzugriff (PDF)

Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study

HemaSphere, 2022-12, Vol.6 (12), p.e803-n/a

2022

Volltextzugriff (PDF)

Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit

Phytomedicine (Stuttgart), 2018-07, Vol.46, p.93-103

2018

Volltextzugriff (PDF)

Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition

Experimental cell research, 2018-09, Vol.370 (2), p.444-453

2018

Volltextzugriff (PDF)

Bruton’s tyrosine kinase (BTK) mediates resistance to EGFR inhibition in non-small-cell lung carcinoma

Oncogenesis (New York, NY), 2021-07, Vol.10 (7), p.56-56, Article 56

2021

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(42)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cancer immunotherapy μ-environment LabChip: taking advantage of optoelectronic tweezers

Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448

Piwi reduction in the aged niche eliminates germline stem cells via Toll-GSK3 signaling

Synergistic disruption of BTK and BCL-2 causes apoptosis while inducing ferroptosis in double-hit lymphoma

Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study

Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors

HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1

Dihydroceramide desaturase regulates the compartmentalization of Rac1 for neuronal oxidative stress

Targeting FAT1 Inhibits Carcinogenesis, Induces Oxidative Stress and Enhances Cisplatin Sensitivity through Deregulation of LRP5/WNT2/GSS Signaling Axis in Oral Squamous Cell Carcinoma

Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma

Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis

Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients

A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit

Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer

4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells

The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity

Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression

Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity

Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy

Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study

Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit

Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition

Bruton’s tyrosine kinase (BTK) mediates resistance to EGFR inhibition in non-small-cell lung carcinoma

Suchergebnisse filtern